These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: A radioimmunoassay for pregnancy associated protein, beta 1SP1: levels in pregnancy, trophoblastic and neoplastic disease.
    Author: Elvers LH, Hiemstra G, Lequin RM.
    Journal: Horm Res; 1980; 12(5):245-52. PubMed ID: 6249709.
    Abstract:
    A radioimmunoassay system for the glycoprotein beta 1SP1, one of the pregnancy-associated proteins, has been set up. beta 1SP1 levels in normal pregnancy have been established transversally. Clearance (t1/2) from the circulation postpartum ranged from 1.4 to 1.8 days. Several patients with trophoblastic disease, e.g., mola hydatidosa, choriocarcinoma and embryonic cell carcinoma, were followed longitudinally. Human chorionic gonadotropin (hCG), a highly reliable tumor marker in trophoblastic disease, has been determined concomitantly by radioimmunoassay. In all instances, hCG proved to be a better indicator of the presence of a tumor, because by the time beta 1SP1 became undetectable, hCG could still be detected. Samples from a large multicenter study on trophoblastic disease were studied: out of 100 positive for hCG, beta 1SP1 could be detected in 86; however, out of 21 samples in which hCG was not detectable, 1 was found to be positive for beta 1SP1. In a number of samples from patients with bronchial carcinoma, no beta 1SP1 could be detected.
    [Abstract] [Full Text] [Related] [New Search]